Food and Drug Administration (FDA) rejected Rep. Raja Krishnamoorthi’s request to temporarily ban the use of e-cigarette products during the delay in the regulatory period caused by the coronavirus crisis.

The FDA said it has issued a ban on most flavored vaping products, with the exception of tobacco and menthol.

In late March, the FDA asked the Federal Court to approve the agency ’s deadline to allow vaping manufacturers to apply for pre-market tobacco applications by four months later, setting the date on September 9. The judge who originally set May 12 as the PMTA deadline stated that he would approve the delay once the court of appeal returned the case to him. The Court of Appeal may decide at any time.

Krishnamoorthi’s application for the Coronavirus caused a temporary ban on the use of vaping products during the delay in the regulatory period, because the use of e-cigarettes may cause serious complications of coronavirus patients. But the evidence, for this reason, is weak, and it is only based on studies of mice and cultured cells. However, insufficient evidence does not prevent anti-e-cigarette fighters from actively promoting an unproven statement.

According to a statement from the supervisory committee, not only did the FDA reject Krishnamoorthi ’s request, but the potential PMTA approval will not be suspended during the coronavirus. Although e-cigarettes may have more serious consequences, the FDA rejected the subcommittee ’s request to suspend all e-cigarette markets.

The statement also said that for safety reasons, FDA will suspend retail compliance enforcement during the coronavirus epidemic.

But the FDA has now changed its stance on vaping and coronaviruses, and it is unclear whether smoking e-cigarettes will increase the risk of new coronaviruses.

Iowa Attorney General Tom Miller, some scientists, health policy experts, and harm reduction advocates wrote a complaint letter to the FDA, stating that banning e-cigarettes may cause many people to re-smoking, smoking on the immune system and the damage caused by vital organs has been confirmed.

Miller reminded the FDA that the FDA should give top priority to the health of millions of Americans and provide reliable and clear advice based on reasonable behavior and biomedical insights. If the FDA’s speech is arbitrary and lacks consideration and no scientific basis, it is easy to cause panic among the people. The consequences are unpredictable, and it is best for the FDA not to comment on such important times.